乳がんスクリーニング検査の世界市場レポート 2025年

乳がんスクリーニング検査の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は8.3％で、34億6,000万米ドルに成長します。予測期間中に予想される成長は、乳がん罹患率の上昇、政府イニシアチブの強化、ヘルスケア支出の増加、移動検診ユニットの拡大、女性人口の増加などに関連しています。この期間に予想される主な動向には、画像診断の技術的進歩、非侵襲的スクリーニング技術の台頭、遺伝子検査の進歩、ゲノム検査の革新、モバイル検診ソリューションの開発などがあります。

乳がん罹患率の増加は、乳がんスクリーニング検査市場の成長を促進すると予想されます。乳がんは、乳房組織における細胞の異常で制御不能な増殖を伴い、腫瘍に発展して他の身体部位に転移する可能性があります。乳がん患者の増加は世界人口の高齢化に起因しており、高齢になると発症リスクが大幅に上昇するためです。乳がんのスクリーニング検査は、乳がんを早期に発見し、治療成績を向上させ、死亡率を低下させるために不可欠です。例えば、米国を拠点とする非営利団体Breastcancer.orgは、2025年3月に、非浸潤性乳管がん（DCIS）の59,080症例とともに、約31万6,950人の女性が2025年に浸潤性乳がんと診断されると予測しました。さらに、2024年12月、カナダ公衆衛生局は、2022年にカナダで推定2万8,600人の女性が乳がんと診断され、5,500人の死亡が予想されると報告しました。その結果、乳がんの有病率の上昇が乳がんスクリーニング検査市場の拡大に寄与しています。

乳がんスクリーニング検査分野の主要企業は、アクセス性の向上、早期発見の増加、サービスが行き届いていない地域や遠隔地へのサービス拡大のため、移動検診ユニットなどの最先端ソリューションの開発を優先しています。これらの移動ユニットは、マンモグラフィのような画像診断技術を備えた移動可能な施設であり、十分なヘルスケアアクセスがない地域でオンサイトの乳がん検診を提供するように設計されています。例えば、2024年9月、インドの製薬会社Granules India Ltd.は、恵まれない地域での乳がん検診を促進するため、Breast Health Expressを導入しました。先進的なマンモグラフィと超音波システムを装備したこの装置は、移動中に質の高い検診を受けられます。このイニシアチブは、農村部や十分なサービスを受けていない地域に早期発見サービスを提供し、これらの地域の女性が重要なヘルスケアにアクセスできるようにすることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の乳がんスクリーニング検査のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の乳がんスクリーニング検査市場：成長率分析
• 世界の乳がんスクリーニング検査市場の実績：規模と成長、2019～2024年
• 世界の乳がんスクリーニング検査市場の予測：規模と成長、2024～2029年、2034年
• 世界の乳がんスクリーニング検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の乳がんスクリーニング検査市場：診断検査タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液マーカー検査
• 画像検査
• 遺伝子検査
• 免疫組織化学検査
• 世界の乳がんスクリーニング検査市場：リスクレベル別、実績と予測、2019～2024年、2024～2029年、2034年
• 高リスク人口
• 中等度リスク人口
• 平均リスク人口
• 世界の乳がんスクリーニング検査市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 診断センター
• がん研究所
• 研究室
• 世界の乳がんスクリーニング検査市場：血液マーカー検査のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 循環腫瘍細胞（CTCS）検査
• 遺伝子発現プロファイリング検査
• 循環腫瘍DNA（CTDNA）検査
• プロテオームバイオマーカー検査
• 世界の乳がんスクリーニング検査市場：画像検査のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• マンモグラフィー
• 磁気共鳴画像スクリーニング検査
• 分子乳房画像検査
• 陽電子放出断層撮影スキャン
• 超音波検査
• 世界の乳がんスクリーニング検査市場：遺伝子検査のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 蛍光in situハイブリダイゼーション
• HER遺伝子検査
• 世界の乳がんスクリーニング検査市場：免疫組織化学（IHC）検査のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• エストロゲン受容体（ER）検査
• Ki-67増殖マーカー検査
• プロゲステロン受容体（Pr）検査
• Her2またはNeu検査

第7章 地域別・国別分析

• 世界の乳がんスクリーニング検査市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の乳がんスクリーニング検査市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 乳がんスクリーニング検査市場：競合情勢
• 乳がんスクリーニング検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Koninklijke Philips NV
• GE HealthCare Technologies Inc.
• Quest Diagnostics Incorporated
• Hologic Inc.
• Hitachi High-Tech Corporation
• Exact Sciences Corporation
• Natera Inc.
• Myriad Genetics Inc.
• Canon Medical Systems Corporation
• Provista Diagnostics Inc.
• POC Medical Systems Inc.
• Niramai Health Analytix Pvt. Ltd.
• Kheiron Medical Technologies Limited
• UE LifeSciences Inc.
• Dxcover Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 乳がんスクリーニング検査市場2029年：新たな機会を提供する国
• 乳がんスクリーニング検査市場2029年：新たな機会を提供するセグメント
• 乳がんスクリーニング検査市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

The breast cancer screening tests market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening tests market statistics, including the breast cancer screening tests industry's global market size, regional shares, competitors with the breast cancer screening tests market share, detailed breast cancer screening tests market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening tests market. This breast cancer screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.31 billion in 2024 to $2.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be credited to enhanced reimbursement policies, a stronger emphasis on preventive healthcare, increased health awareness, greater investment in research and development, and heightened awareness regarding early detection.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be linked to the rising incidence of breast cancer, increased government initiatives, growing healthcare spending, the expansion of mobile screening units, and a rise in the female population. Key trends expected during this period include technological advancements in imaging, the emergence of non-invasive screening techniques, progress in genetic testing, innovations in genomic testing, and the development of mobile screening solutions.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major players in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., POC Medical Systems Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., Dxcover Limited.

North America was the largest region in the breast cancer screening test market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in breast cancer screening test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
• 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
• 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories

Subsegments

• 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
• 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Tomograph Scan; Ultrasound
• 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
• 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Breast Cancer Screening Test Market Characteristics

3. Breast Cancer Screening Test Market Trends And Strategies

4. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Breast Cancer Screening Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Breast Cancer Screening Test Market Growth Rate Analysis
• 5.4. Global Breast Cancer Screening Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Breast Cancer Screening Test Total Addressable Market (TAM)

6. Breast Cancer Screening Test Market Segmentation

• 6.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Marker Test
• Imaging Test
• Genetic Test
• Immunohistochemistry Test
• 6.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-risk Population
• Moderate-risk Population
• Average-risk Population
• 6.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centres
• Cancer Institutes
• Research Laboratories
• 6.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Circulating Tumor Cells (Ctcs) Test
• Gene Expression Profiling Test
• Circulating Tumor Dna (Ctdna) Test
• Proteomic Biomarker Test
• 6.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammography
• Magnetic Resonance Imaging Screening Test
• Molecular Breast Imaging Test
• Positron Emission Tomograph Scan
• Ultrasound
• 6.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescence In Situ Hybridization
• Her Gene Test
• 6.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry (Ihc) Test, By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen Receptor (Er) Test
• Ki-67 Proliferation Marker Test
• Progesterone Receptor (Pr) Test
• Her2 Or Neu Test

7. Breast Cancer Screening Test Market Regional And Country Analysis

• 7.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Breast Cancer Screening Test Market

• 8.1. Asia-Pacific Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Breast Cancer Screening Test Market

• 9.1. China Breast Cancer Screening Test Market Overview
• 9.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Breast Cancer Screening Test Market

• 10.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Breast Cancer Screening Test Market

• 11.1. Japan Breast Cancer Screening Test Market Overview
• 11.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Breast Cancer Screening Test Market

• 12.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Breast Cancer Screening Test Market

• 13.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Breast Cancer Screening Test Market

• 14.1. South Korea Breast Cancer Screening Test Market Overview
• 14.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Breast Cancer Screening Test Market

• 15.1. Western Europe Breast Cancer Screening Test Market Overview
• 15.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Breast Cancer Screening Test Market

• 16.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Breast Cancer Screening Test Market

• 17.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Breast Cancer Screening Test Market

• 18.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Breast Cancer Screening Test Market

• 19.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Breast Cancer Screening Test Market

• 20.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Breast Cancer Screening Test Market

• 21.1. Eastern Europe Breast Cancer Screening Test Market Overview
• 21.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Breast Cancer Screening Test Market

• 22.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Breast Cancer Screening Test Market

• 23.1. North America Breast Cancer Screening Test Market Overview
• 23.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Breast Cancer Screening Test Market

• 24.1. USA Breast Cancer Screening Test Market Overview
• 24.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Breast Cancer Screening Test Market

• 25.1. Canada Breast Cancer Screening Test Market Overview
• 25.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Breast Cancer Screening Test Market

• 26.1. South America Breast Cancer Screening Test Market Overview
• 26.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Breast Cancer Screening Test Market

• 27.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Breast Cancer Screening Test Market

• 28.1. Middle East Breast Cancer Screening Test Market Overview
• 28.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Breast Cancer Screening Test Market

• 29.1. Africa Breast Cancer Screening Test Market Overview
• 29.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

• 30.1. Breast Cancer Screening Test Market Competitive Landscape
• 30.2. Breast Cancer Screening Test Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Breast Cancer Screening Test Market Other Major And Innovative Companies

• 31.1. Koninklijke Philips NV
• 31.2. GE HealthCare Technologies Inc.
• 31.3. Quest Diagnostics Incorporated
• 31.4. Hologic Inc.
• 31.5. Hitachi High-Tech Corporation
• 31.6. Exact Sciences Corporation
• 31.7. Natera Inc.
• 31.8. Myriad Genetics Inc.
• 31.9. Canon Medical Systems Corporation
• 31.10. Provista Diagnostics Inc.
• 31.11. POC Medical Systems Inc.
• 31.12. Niramai Health Analytix Pvt. Ltd.
• 31.13. Kheiron Medical Technologies Limited
• 31.14. UE LifeSciences Inc.
• 31.15. Dxcover Limited

32. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

34. Recent Developments In The Breast Cancer Screening Test Market

35. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

• 35.1 Breast Cancer Screening Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Breast Cancer Screening Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Breast Cancer Screening Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer